Caas Capital Management LP Pfizer Inc Put Options Transaction History

Caas Capital Management LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $269,139 - $349,582	10,300 New	10,300 $296,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $531,765 - $692,280	13,500 New	13,500 $550,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $2.43 Million - $2.89 Million	52,300 Added 1341.03%	56,200 $2.95 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $4.93 Million - $6.11 Million	-107,800 Reduced 96.51%	3,900 $202,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $4.62 Million - $6.84 Million	111,700 New	111,700 $6.6 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $46,858 - $59,584	-1,400 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $42,168 - $51,156	1,400 New	1,400 $46,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.